Streamlining HCT Referrals
Explore Cell Therapy podcast season 2, episode 12
In this two-part "Explore Cell Therapy" podcast episode, Jonathan Fish, MD, and Joanna Pierro, DO, discuss the transformative impact of a streamlined referral process at Cohen Children’s Medical Center to simplify setting up consultations for hematopoietic cell transplant (HCT).
Experts explore how this simple system created using RedCap software can help overcome logistical barriers and enhance coordinated care through a single point of entry for referrals. Learn how early logistical planning and improved communication channels can increase referral volumes, optimize patient outcomes, and support the introduction of groundbreaking new cell and gene therapy options. This episode is a must-listen for insights into improving patient care coordination and enhancing patient outcomes through timely consultation and transplant.
Key takeaways
- Streamlined Referral Process: The implementation of a single entry point for referrals through RedCap has streamlined requests for transplant and cell therapy consult from hematology/oncology practices to Cohen Children’s Medical Center, ensuring timely and easy access to care.
- Addressing Barriers: The system mitigates challenges such as inconsistent referral processes, geographical obstacles, and logistical issues, allowing for timely and reliable referrals with more time to address patient barriers to care and ensure optimal outcomes.
- Enhanced Coordination to Improve Outcomes: Early logistical planning and social work support are facilitated by the new referral system, crucial for complex procedures like transplant, ultimately improving patient care and outcomes. The system has allowed for quicker responses to referrals, which is critical for timely interventions including transplant and CAR-T therapies.
- Impact and Quality Measures: An increase in referral volume is noted, with plans to measure its impact on patient outcomes, emphasizing the system's role as a quality improvement tool, especially with new therapies like gene therapy for thalassemia and sickle cell disease.
- Collaboration and Communication: The importance of collaboration and communication was stressed, both within and between institutions. The referral system has fostered better communication channels, making it easier for referring providers to get timely responses and improving overall patient care coordination.
This episode's expert guests
Jonathan Fish, MD
Cohen Children’s Medical Center
Joanna Pierro, DO
Staten Island University Hospital
- Listen to Part 1: Overcoming Barriers through Coordinated Care
- Listen to Part 2: Assessing the Impact and Future State
Access all "Explore Cell Therapy" episodes
Listen to "Explore Cell Therapy" on Spotify
Featured programs discussed in this episode
This program for hematology/oncology practices provides free HLA typing for patients and their family members in the community before they reach the transplant center.
Resources for hematology/oncology and transplant physicians
This new and improved app features our latest HCT Consultation Timing Guidelines, Post-Transplant Care Guidelines, tips to help identify GVHD, CME opportunities and more.
Transplant Center Directory for hematology/oncology physicians
This searchable database provides details on the transplant centers, such as center contact information, number of transplants by cell source, patient survival information and more.
CIBMTR Summary Slides and Reports
CIBMTR data on outcomes and trends are summarized and made available for clinical decision-making, presentations, and research planning.
Resources for your patients
The NMDP Patient Support Center provides support, information and resources for transplant patients, caregivers and families. All our programs and resources are free.
Jason Carter Clinical Trials Search and Support Program
The Clinical Trials Search and Support program helps patients find and join clinical trials through one-on-one support, an easy-to-navigate website, and financial assistance to help patients pay for travel costs to participate in a clinical trial.